An investigation of drug-resistant Acinetobacter baumannii infections in a comprehensive hospital of East China

Annals of Clinical Microbiology and Antimicrobials

Volumn 14, Issue 1, 2015, Pages

  Zhao, Su ying ^a   Jiang, Dong yang ^b   Xu, Peng cheng ^b   Zhang, Yi kai ^b   Shi, Heng fang ^a   Cao, Hui ling ^a   Wu, Qian ^b,c  

^a AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Acinetobacter baumannii; Drug resistant gene; PCR; PFGE

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL DNA; BACTERIAL RNA; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOPERAZONE PLUS SULBACTAM; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA FRAGMENT; GENOMIC DNA; GENTAMICIN; IMIPENEM; INTEGRASE; INTEGRASE 1; LEVOFLOXACIN; NITROFURANTOIN; OUTER MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; QUATERNARY AMMONIUM DERIVATIVE; RNA 16S; SULTAMICILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHINA; CLONE; CONTROLLED STUDY; FEMALE; GENE; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; OXA 23 GENE; OXA 51 GENE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEX RATIO; VERY ELDERLY; ACINETOBACTER INFECTIONS; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHINA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 84924360269     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-015-0066-4     Document Type: Article

References (32)

1. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254-63.
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939-51.
3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
4. Wang F, Zhu D, Hu F, Jiang X, Hu Z, Li Q, et al. CHINET 2013 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2014;14(5):369-78.
5. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826-36.
6. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006;55:1619-29.
7. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358:1271-81.
8. Livermore DM. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs. 2002;3:218-24.
9. Mussi MA, Relling VM, Limansky AS, Viale AM. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett. 2007;581:5573-8.
10. Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;16;289(1036):321-31.
11. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53(Pt 12):1233-40.
12. Fonseca EL, Scheidegger E, Freitas FS, Cipriano R, Vicente AC. Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene. BMC Microbiol. 2013;13:245.
13. Mahzounieh M, Khoshnood S, Ebrahimi A, Habibian S, Yaghoubian M. Detection of Antiseptic-Resistance Genes in Pseudomonas and Acinetobacter spp. Isolated From Burn Patients. Jundishapur. J Nat Pharm Prod. 2014;9(2):e15402.
14. Kaufmann ME, Pitt TL. Pulsed-field gel electrophoresis of bacterial DNA. In: Methods in practical laboratory bacteriology. Boca Raton, FL: CRC Press; 1994. p. 83-92.
15. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
16. Munoz-Pric LS, Robert AW. Acinetobacter Infection. N Engl Med. 2008;258(26):1271-81.
17. Perez F, Hujer AM, Metal HK. Global challenge of multidrug-resistant Acinetobacter baurnannii. Antimicrob Agents Chemother. 2007;51:3471-84.
18. Rello J. Acinetobacter baumannii infections in the ICU: customization is the key. Chest. 1999;115(5):1226-9.
19. Livermore DM, Woodford N. Carbapenemases: a problem in waiting. Curr Opin Microbiol. 2000;3(5):489-95.
20. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23,-24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations:report from the SENTRY Surveillance Program. J Antimicrob Chemother. 2009;63(1):55-9.
21. Merkier AK, Centrón D. blaOXA-51-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents. 2006;28(2):110-3.
22. Mugnier PD, Poirel L, Naas T. Nordmann P.v Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16:35-40.
23. Yinmei Y, Zhaohui L, Wei hong Z, Huifen Y, Huiling C. Identification of aac(6')-Ib and aac(6)-Ib-cr gene in Acinetobacter baumannii. Public Health and. Clin Med. 2010;6(3):191-3.
24. Limansky AS, Mussi MA, Viale AM. Loss of a 29, Kilodalton outer Membrane Protein in Acinetobacter baumann if Is Associated with imipenem resistance. J Clin Microbiol. 2002;40(12):4776-8.
25. Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Rev. 1996;60(4):575-608.
26. Paulsen IT, Littlejohn TG, Radstrom P, Sundstrom L, Skold O, Swedberg G, et al. The 3' conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob Agents Chemother. 1993;37(4):761-8.
27. Skold O. Sulfonamide resistance: mechanisms and trends. Drug Resist. 2000;3:155-60.
28. Skold O. R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase. Antimicrob Agents Chemother. 1976;9:49-54.
29. Hall RM, Collis CM. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist Updates. 1998;1:109-19.
30. Orman BE, Piñeiro SA, Arduino S, Galas M, Melano R, Caffer MI, et al. Evolution of multiresistance in nontyphoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob Agents Chemother. 2002;46:3963-70.
31. Fluit AC, Schmitz FJ. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis. 1999;18(11):761-70.
32. Tenover FC, Arbeit RD, Goering RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. The Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1997;1(6):426-39.